Pharma News

The global generic medicines market

Home/Pharma News | Posted 03/09/2010

The global market for generic drugs was worth an estimated US$84 billion for 2009 and is expected to increase to a staggering US$168.7 billion by 2014.

Generics’ manufacturer Hospira merges with Javelin

Home/Pharma News | Posted 10/08/2010

On 22 June 2010, Hospira announced that it had successfully acquired 79% of the stock in Javelin Pharmaceutical’s. The merger agreement also allows for Hospira to exercise a ‘top-up’ option to increase its share ownership in Javelin, which, states Hospira, it fully intends to do.

Sanofi-aventis and Nichi-Iko announce joint venture for generics in Japan

Home/Pharma News | Posted 02/07/2010

Sanofi-aventis and Nichi-Iko Pharmaceutical Co., Ltd. (Nichi-Iko) have announced that they have signed an agreement to establish a new joint venture, called sanofi-aventis Nichi-Iko KK, in order to develop a generic business in Japan.

Orchid acquires US generic sales and marketing company Karalex

Home/Pharma News | Posted 25/06/2010

On 10 June 2010, Indian-based generics manufacturer, Orchid Chemicals & Pharmaceuticals (Orchid) announced that it had entered into an agreement to acquire Karalex Pharma, LLC, a US-based generic marketing and sales services company with headquarters in New Jersey, USA.

GSK acquires Argentine generics’ maker Laboratorios Phoenix

Home/Pharma News | Posted 25/06/2010

On 10 June 2010 GlaxoSmithKline (GSK) acquired Laboratorios Phoenix, a leading Argentine pharmaceutical business, for approximately US$253 million. GSK will gain full ownership of Phoenix in a move to accelerate sales growth and further extend its pharmaceutical portfolio in Argentina and the Latin America region.

Abbott acquires Indian generics’ maker Piramal Healthcare

Home/Pharma News | Posted 18/06/2010

The US-based company, Abbott, agreed to buy the domestic unit of Piramal Healthcare, one of India’s biggest generics makers, for US$3.7 billion.

EGA welcomes MEPs decisions on falsified medicines and pharmacovigilance reports

Home/Pharma News | Posted 11/06/2010

On 27 April 2010, ENVI (The Committee on the Environment, Public Health and Food Safety) of the European Parliament voted to adopt reports on both falsified medicines and pharmacovigilance. The measures included in these reports are intended to increase patients’ safety. This can only be good news for the generics sector, as this should result in increased consumer confidence and as a result encourage acceptance and increase sales of generics.

IMS Health Top 20 pharmaceutical companies 2009

Home/Pharma News | Posted 23/04/2010

The 2009 list of the top 20 pharmaceutical companies, ranked by IMS Health according to global prescription drug sales for the 12 months up to September 2009, shows that Teva, Novo Nordisk and Boehringer Ingelheim scored better in percent change than Big Pharma in those months.

IMS Health, BCC: Generics sales continue to climb

Home/Pharma News | Posted 12/03/2010

Over the 12 months that ended September 2009, global sales of generics grew by 7.7%, up from 3.6 % the year before, IMS Health reported. This compares with the 5.7% growth seen within the overall global pharmaceutical universe in 2009.

Global generics: time for consolidation and expansion

Home/Pharma News | Posted 12/03/2010

The global generic drug industry has witnessed an almost decade-long sales euphoria. Volumes and sales growth of prescription generic drugs continued to increase in 2009. At the same time, large companies are consolidating their operations in established markets and/or expanding into emerging ones through local acquisitions or partnerships.